Literature DB >> 2030628

Correlations between histopathological and biological findings in nasopharyngeal carcinoma and its prognostic significance.

O Gallo1, S Bianchi, A Giannini, E Gallina, G A Libonati, O Fini-Storchi.   

Abstract

Forty-five consecutive cases of nasopharyngeal carcinoma were morphologically and immunocytochemically studied using monoclonal (anti-B and anti-T cell) and polyclonal (anti-S100 protein and antilysozyme) antibodies with the peroxidase-anti-peroxidase method to identify infiltrating lymphocytes (T and B cell) and histiocytes (monocytic/macrophagic and dendritic cells) in nasopharyngeal carcinoma. A variable density of dendritic cells was found within the tumor nests in 22 (49%) of 45 nasopharyngeal carcinomas examined; infiltrating macrophages were demonstrated in 15 (33%) specimens and around the tumor in almost all cases. Cases with moderate or marked density of dendritic cells (S100+) survived longer than those without such infiltration (mean 5-year survival rates of 31%, 55%, or 64% in patients with absent, moderate, or marked densities, respectively; P less than 0.05). A significant relationship between monocytic/macrophagic cells (lysozyme+) within the tumor and survival was also found (mean 5-year survival rate of 27% or 61% in patients with absent, moderate, or marked densities, respectively). However, lymphocytic infiltration was not statistically related to a better survival. Analyzing lymphocytic infiltration, we found a large prevalence of T cells in the neoplastic tissue without any prognostic significance. These data were correlated to different histological subtypes according to the principal histological classifications of nasopharyngeal carcinomas (Micheau, et al.; World Health Organization; Cologne University) to individualize the scheme which correlates best with prognosis and biological features of nasopharyngeal carcinomas. Our data suggest that, considering dendritic cells and macrophages within cancer nests, nasopharyngeal carcinoma histiotypes can be correlated to patient prognosis.

Entities:  

Mesh:

Year:  1991        PMID: 2030628     DOI: 10.1288/00005537-199105000-00008

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

Review 1.  Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored.

Authors:  Jan Buter; Herbert M Pinedo
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

2.  Association of Protein Expression p53 Mutants with Regional Lymph Gland Status on type III Carcinoma Nasofaring Patients.

Authors:  Riza Aswarin; Muhtarum Yusuf; M S Wiyadi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-21

3.  Paucilymphoid non-keratinizing nasopharyngeal carcinoma with prominent stromal desmoplasia--an unusual case reported with brief comments on uncommon histological variants.

Authors:  Fredrik Petersson; Kwok Seng Loh; Diana Lim
Journal:  Int J Clin Exp Pathol       Date:  2011-04-03

Review 4.  BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.

Authors:  Eveline K Hoebe; Tessa Y S Le Large; Astrid E Greijer; Jaap M Middeldorp
Journal:  Rev Med Virol       Date:  2013-08-31       Impact factor: 6.989

5.  Diagnostic usefulness of telomerase activity in nasopharyngeal carcinoma.

Authors:  C F Hwang; C Y Su; S C Kou; S C Huang; S W Leung; C M Huang; C L Cho
Journal:  Jpn J Cancer Res       Date:  2000-07

6.  Dendritic Cells Are Associated with Prognosis and Survival in Breast Cancer.

Authors:  Joanna Szpor; Joanna Streb; Anna Glajcar; Paulina Frączek; Aleksandra Winiarska; Katarzyna E Tyrak; Paweł Basta; Krzysztof Okoń; Robert Jach; Diana Hodorowicz-Zaniewska
Journal:  Diagnostics (Basel)       Date:  2021-04-14

Review 7.  Nasopharyngeal Carcinoma and Its Microenvironment: Past, Current, and Future Perspectives.

Authors:  Zhi Yi Su; Pui Yan Siak; Chee-Onn Leong; Shiau-Chuen Cheah
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 6.244

8.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

9.  CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer.

Authors:  B J Coventry; J Morton
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.